Dr. Natalie Torok's lab investigates the molecular mechanisms of liver fibrosis,  focusing on the role of oxidative pathways in non-alcoholic and alcoholic steatohepatitis.

Dr. Torok's lab has demonstrated the intricate link between hepatocyte cell death, generation of apoptotic bodies and their phagocytosis by stellate cells triggering fibrogenic activation. Key to this was the activation of the NADPH oxidase and production of reactive oxidative species inducing stellate cell transdifferentiation and collagen I transcription.

Dr. Natalia Serna is an Assistant Professor in the Department of Health Policy at Stanford University and a SIEPR and Stanford Global Health Faculty Fellow. 

Dr. Serna's research agenda lies at the intersection of industrial organization of health care markets and health outcomes research. She is specifically interested in how health insurance plan design affects patient outcomes and doctor decision making. 

Dr. Gozde Durmus's research focuses on applying micro/nano-technologies to investigate cellular heterogeneity for single-cell analysis and personalized medicine. At Stanford, she is developing platform technologies for sorting and monitoring cells at the single-cell resolution. This magnetic levitation-based technology is used for wide range of applications in medicine, such as, label-free detection of circulating tumor cells (CTCs) from blood; high-throughput drug screening; and rapid detection and monitoring of antibiotic resistance in real-time.

Dr. Kochenderfer is the director of the Stanford Intelligent Systems Laboratory (SISL), conducting research on advanced algorithms and analytical methods for the design of robust decision making systems, particularly systems for air traffic control, unmanned aircraft, and other aerospace applications where decisions must be made in uncertain, dynamic environments while maintaining safety and efficiency.